Home/Pipeline/Wearable Neuromodulation Therapy

Wearable Neuromodulation Therapy

Obstructive Sleep Apnea

Pre-clinicalActive

Key Facts

Indication

Obstructive Sleep Apnea

Phase

Pre-clinical

Status

Active

Company

XII Medical

About XII Medical

XII Medical is a private, clinical-stage medical device and digital health company targeting the large and underserved Obstructive Sleep Apnea (OSA) market. The company is developing a best-in-class, smart wearable neuromodulation therapy designed to be a simpler and more accessible alternative to current standard treatments like CPAP. Leveraging integrated hardware and software, XII Medical seeks to address low patient adherence rates and improve long-term disease management. Its focus on a streamlined, patient-centric solution positions it in a high-growth segment of the digital therapeutics and neurostimulation landscape.

View full company profile

Therapeutic Areas

Obstructive Sleep Apnea Sleep Disorders

Other Obstructive Sleep Apnea Drugs

Drug	Company	Phase	Status
SANSA® Home Sleep Apnea Test (HSAT)	Huxley Medical	Approved	Active
Nasal Spray for OSA	Mosanna Therapeutics	Pre-clinical	Active
Transcend Micro 510 Auto CPAP	Somnetics	Approved	Active
iNAP One Sleep Therapy System	Somnics Health	Commercial	Active
iNAP Adjustable	Somnics Health	Commercial	Active
WatchPAT® Home Sleep Apnea Test (HSAT)	Itamar Medical	Commercial	Active
WatchPAT ONE	Itamar Medical	Commercial	Active
Tirzepatide	Eli Lilly	Phase 3	Completed (SURMOUNT-OSA)
WiZARD CPAP Mask	Wellell	Commercial	Active
iCH Auto CPAP System	Wellell	Commercial	Active